Keywords: merrion, add, gipet, h-f, neuroprotectant, hunter-fleming, uk-based
Merrion to add GIPET to H-F's neuroprotectant
Article | 24 July 2006
Hunter-Fleming, a UK-based biopharmaceutical company focused on neurological and cardiac disorders, has commenced an oral drug-delivery research collaboration with the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
